Full-Time

Neuroscience Biology Lead

Posted on 6/27/2024

Manifold Bio

Manifold Bio

11-50 employees

Designs precision biologics using in vivo methods

Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Biology Ph.D. or equivalent experience
  • Experience designing screening funnels leveraging both in vitro and in vivo assays with a focus on biologics (5-10 for Dir. level; 10+ for VP level)
  • Previous experience as a team lead or co-lead in an industry setting
  • Experience with hybrid drug discovery models blending external and internal R&D workflows
  • Highly independent and proactive, excellent communication and cross-functional team coordination skills
  • Experience with molecules that enhance BBB transcytosis (e.g. ‘shuttles’)
  • Experience and interest in assay development (in vitro/ex vivo/in vivo)
  • Experience with preclinical development and clinical trial planning
Responsibilities
  • Guide company level neuroscience / CNS strategy
  • Evaluate new project/target opportunities and propose POC experiments
  • Leverage external resources and coordinate internal team members to lead projects from discovery to candidate selection
  • Coordinate with protein engineering on binder discovery and/or evaluate in-licensing opportunities, considering tradeoffs among target presentation and relation to disease biology
  • Design screening funnels that integrate our novel mDesign in vivo biologics design platform
  • Analyze and interpret data to enable decision making
  • Design development plans to early human PoC, including specifying DC nomination criteria

Manifold Bio focuses on creating precision biologics for the pharmaceutical industry. Their main product is an in vivo drug design platform, which allows for drug testing within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment. This capability is especially beneficial for testing complex biologics, which are large molecule drugs derived from living organisms. Manifold Bio stands out from competitors by being the first to offer this in vivo drug design approach. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Company Stage

Series A

Total Funding

$58.8M

Headquarters

Boston, Massachusetts

Founded

2020

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $40M in Series A funding, indicating strong market interest.
  • Major investors like Tencent and Horizons Ventures show confidence in their innovation.
  • Their technology addresses the in vivo testing bottleneck in drug development.

What critics are saying

  • Emerging competition in protein barcoding could threaten their market position.
  • Rapid AI advancements may outpace their current platform capabilities.
  • Regulatory challenges could delay multiplexed in vivo testing approvals.

What makes Manifold Bio unique

  • Manifold Bio's mCodes™ technology enables multiplexed protein analysis in vivo.
  • Their platform allows simultaneous testing of multiple molecules in living systems.
  • They are pioneering in vivo biologics design, a first in the pharmaceutical industry.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE